secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001193125-25-283935
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics gets Nasdaq extension until May 11, 2026 to regain $1 bid price
--------------------------------------------------------------------------------

- Received 180-day extension to May 11, 2026 from Nasdaq to meet $1.00 minimum bid price rule.
- No immediate effect on listing; stock continues trading on Nasdaq under PSTV.
- If bid price closes at $1.00+ for 10 consecutive days, compliance confirmed and matter closed.
- Company may implement reverse stock split if needed; no guarantee of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525283935/0001193125-25-283935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525283935/d55484d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-283935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer